Scripta Therapeutics

Based in the United Kingdom, Scripta Therapeutics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Scripta Therapeutics is a techbio company that uses AI, imaging, and patient-derived models to create disease maps based on transcriptional networks, aiming to discover disease-modifying drugs that modulate transcription factor activity to restore healthy cell states, initially focusing on Alzheimer's disease and other neurodegenerative conditions.